Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Hyderabad
- Most recent report
- 6-K, filed Sep 22, 2026
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 1135951
- Fiscal year ends
- March
- Filer status
- Large accelerated filer
Financials 8 of 953
- 6-K Report a foreign issuer made public elsewhere Sep 22, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 21, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 18, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 14, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 10, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 10, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 26, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 17, 2026
Prospectuses and Registrations 1
Ownership 8 of 42
- 3 Insider reported their initial holding Apr 10, 2026
- 3 Insider reported their initial holding Apr 1, 2026
- 3 Insider reported their initial holding Apr 1, 2026
- 3 Insider reported their initial holding Apr 1, 2026
- 3 Insider reported their initial holding Apr 1, 2026
- 3 Insider reported their initial holding Apr 1, 2026
- 3 Insider reported their initial holding Apr 1, 2026
- 3 Insider reported their initial holding Apr 1, 2026
Other 4
Everything here comes from Dr Reddys Laboratories Ltd's own filings on SEC EDGAR. The filing list is rechecked every hour.